GlycoMimetics (NASDAQ:GLYC – Get Free Report) will post its quarterly earnings results before the market opens on Wednesday, August 2nd. Analysts expect GlycoMimetics to post earnings of ($0.18) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. GlycoMimetics (NASDAQ:GLYC – Get Free […]
GlycoMimetics (NASDAQ:GLYC – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, August 2nd. Analysts expect GlycoMimetics to post earnings of ($0.18) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. GlycoMimetics (NASDAQ:GLYC – […]
GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $2.05 and traded as low as $1.77. GlycoMimetics shares last traded at $1.80, with a volume of 226,481 shares changing hands. Analyst Ratings Changes GLYC has […]
NEA Management Company LLC lessened its holdings in shares of GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) by 1.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 8,967,706 shares of the biotechnology company’s stock after selling 121,335 shares during the period. GlycoMimetics makes up approximately 1.5% of NEA […]
StockNews.com began coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $8.00 target price on shares of GlycoMimetics in a report on Thursday, March 30th. […]